Skip to content

Clinical trials

Pulmonary Disease, Chronic Obstructive trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Not applicable Clear all

2,021 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20028
200311
200415
200523
200619
200730
200841
200967
201051
201176
201270
201386
201495
201580
2016124
2017121
2018100
2019140
202092
2021108
2022120
2023131
2024140
2025124
2026135

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,152
Unknown status337
Recruiting198
Not yet recruiting110
Terminated104
Active, not recruiting54
Withdrawn46
Enrolling by invitation13
Suspended7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Riphah International University54
Schön Klinik Berchtesgadener Land30
VA Office of Research and Development30
Laval University19
Imperial College London17
University of Zurich16
KU Leuven15
China-Japan Friendship Hospital13
Mayo Clinic13
University of Aarhus13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive2,021
Dyspnea136
Asthma132
Heart Failure115
Emphysema79
Lung Diseases65
Anxiety Disorders49
Diabetes Mellitus49
Lung Diseases, Interstitial44
Bronchitis, Chronic43

Trials

Showing 1 to 25 of 2,021. Each trial links to its page on Pharma Observatory.

1,921 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.